Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
85 pending office actions • 57 art units • 82 examiners • 0 of 85 (0%) have an AI response strategy ready • 72 patents granted in the last 365 days
Washington University has 79 pending office actions within the Biotechnology & Pharmaceuticals technology area. The prosecution is exceptionally decentralized, involving 76 distinct examiners across 54 distinct art units. This high number of 54 distinct art units relative to the 79 total actions suggests that the university's research and resulting patent applications cover an extremely broad range of biological and pharmaceutical sub-disciplines. The involvement of 76 distinct examiners means that almost every pending application is being reviewed by a different individual.
Bailey Michelle Morgan is the busiest examiner for the portfolio, with 2 pending office actions. This represents a minimal concentration given the 79 pending office actions overall. With 76 distinct examiners, practitioners must be prepared for a vast array of examination styles and technical perspectives. The 54 distinct art units indicate that the portfolio is not concentrated in any single specialized area, but rather distributed across a wide section of the USPTO's examination corps. This decentralized structure requires a highly adaptable prosecution strategy to accommodate 76 distinct examiners.
Based on the USPTO statutory response window for each pending office action. 29 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 29 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 20 (24%) |
| §103 only | 20 (24%) |
| §112 only | 10 (12%) |
| Double-patenting only | 3 (4%) |
| Double-patenting + other | 2 (2%) |
| Multi-statute (no §101) | 30 (35%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MORGAN, BAILEY MICHELLE | 2 | 56.3% | +58.3% |
| KALLAL, ROBERT JAMES | 2 | 60.0% | +32.4% |
| DUNN, MCKENZIE A | 2 | 53.8% | +56.3% |
| DAVIS, AMELIE R | 1 | 65.0% | +33.4% |
| DRISCOLL, LORA E BARNHART | 1 | 32.0% | +20.0% |
| TADAYYON ESLAMI, TABASSOM | 1 | 49.5% | +26.5% |
| SALVATORE, LYNDA | 1 | 64.1% | +19.4% |
| ADAMS, WILLIAM PATRICK | 1 | — | — |
| CAMMARATA, MICHAEL ROBERT | 1 | 69.8% | +34.5% |
| LAGOY, KYRA RAND | 1 | 9.5% | -11.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17699053 | GENOME SEQUENCING AS AN ALTERNATIVE TO CYTOGENETIC ANALYSIS | SMITH, EMILIE ALINE | 169d overdue |
| 18310412 | ULTRAHIGH-SPEED MULTI-PARAMETRIC PHOTOACOUSTIC MICROSCOPY BASED ON A THIN-FILM OPTICAL-ACOUSTIC COMBINER | MENDOZA, ALEXANDRIA ARELLANO | 93d overdue |
| 18818523 | METHODS OF DETECTING ONCOGENIC FUSIONS AND USES THEREOF | LEITH, NANCY J | 43d overdue |
| 17914817 | Uses of Tau Phosphosites as Biomarkers for Alzheimer's Disease | FONTAINHAS, AURORA M | 42d overdue |
| 17628497 | PARTICLE-BASED METHOD FOR DEFINING A GUT MICROBIOTA IN HUMANS OR OTHER ANIMAL SPECIES | JONES, DAMERON LEVEST | 36d overdue |
| 18590933 | AEROSOL CONTAINMENT MASK AND METHODS OF USE THEREOF | LEE, MICHELLE J | 32d overdue |
| 18855529 | SYSTEMS AND METHODS FOR EXTRACTING CLINICAL PHENOTYPES FOR ALZHEIMER DISEASE DEMENTIA FROM UNSTRUCTURED CLINICAL RECORDS USING NATURAL LANGUAGE PROCESSING | LAGOY, KYRA RAND | 11d overdue |
| 17916180 | IMPLANT DEVICES AND METHODS FOR TREATMENT OF CERVICAL CANCER | WORSHAM, JESSICA N | 8d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19358923 | ULTRASOUND SENSING AND IMAGING BASED ON WHISPERING-GALLERY-MODE (WGM) MICRORESONATORS | DAVIS, AMELIE R | — |
| 19312085 | RECOMBINANT ADENOVIRUSES AND USE THEREOF | DRISCOLL, LORA E BARNHART | — |
| 19170154 | CATALYST AND METHOD FOR CONVERTING CO2 TO SOLID CARBON, AND COMPOSITES INCLUDING SOLID CARBON | TADAYYON ESLAMI, TABASSOM | — |
| 19028550 | BIOMEDICAL PATCHES WITH SPATIALLY ARRANGED FIBERS | SALVATORE, LYNDA | — |
| 18970827 | COMPUTATIONAL REFOCUSING-ASSISTED DEEP LEARNING | CAMMARATA, MICHAEL ROBERT | — |
| 18732214 | ANTI-ROXP ANTIBODIES AND USES THEREOF | MORGAN, BAILEY MICHELLE | — |
| 18666803 | RHODOPSEUDOMONAS PALUSTRIS TIE-1 STRAINS AND METHODS FOR BIOPLASTIC PRODUCTION | MORGAN, BAILEY MICHELLE | — |
| 18550797 | SPECTRAL CORRELATION ANALYSIS OF LAYERED EVOLUTIONARY SIGNALS | KALLAL, ROBERT JAMES | — |
| Art Unit | Apps |
|---|---|
| 3798 | 3 |
| 1645 | 3 |
| 3791 | 3 |
| 1675 | 3 |
| 1678 | 3 |
| 1718 | 2 |
| 3783 | 2 |
| 1635 | 2 |
| 1632 | 2 |
| 1631 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19358923 | ULTRASOUND SENSING AND IMAGING BASED ON WHISPERING-GALLERY-MODE (WGM) MICRORESONATORS | DAVIS, AMELIE R | 3798 | §112Other | Non-Final OA | — | Pending | Oct 15, 2025 |
| 19312085 | RECOMBINANT ADENOVIRUSES AND USE THEREOF | DRISCOLL, LORA E BARNHART | 3991 | §101DP | Non-Final OA | — | Pending | Aug 27, 2025 |
| 19170154 | CATALYST AND METHOD FOR CONVERTING CO2 TO SOLID CARBON, AND COMPOSITES INCLUDING SOLID CARBON | TADAYYON ESLAMI, TABASSOM | 1718 | §102§103§112 | Final Rejection | — | Pending | Apr 04, 2025 |
| 19028550 | BIOMEDICAL PATCHES WITH SPATIALLY ARRANGED FIBERS | SALVATORE, LYNDA | 1789 | DP | Final Rejection | — | Pending | Jan 17, 2025 |
| 18980157 | SYSTEMS AND METHODS FOR AUTOMATED ELECTROCARDIOGRAM (ECG) INTERPRETATION OF WIDE COMPLEX RHYTHMS | ADAMS, WILLIAM PATRICK | — | §101§102§103§112Other | Non-Final OA | — | Pending | Dec 13, 2024 |
| 18970827 | COMPUTATIONAL REFOCUSING-ASSISTED DEEP LEARNING | CAMMARATA, MICHAEL ROBERT | — | §102§103Other | Non-Final OA | — | Pending | Dec 05, 2024 |
| 18855529 | SYSTEMS AND METHODS FOR EXTRACTING CLINICAL PHENOTYPES FOR ALZHEIMER DISEASE DEMENTIA FROM UNSTRUCTURED CLINICAL RECORDS USING NATURAL LANGUAGE PROCESSING | LAGOY, KYRA RAND | 3685 | §101§103§112 | Non-Final OA | 11d overdue | Pending | Oct 09, 2024 |
| 18886294 | Near Infrared Fluorescent Dyes, Formulations and Related Methods | CABRAL, ROBERT S | — | DP | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18830098 | SIGMA-2 RECEPTOR LIGAND DRUG CONJUGATES AS ANTITUMOR COMPOUNDS, METHODS OF SYNTHESIS AND USES THEREOF | PECKHAM, RICHARD GRANT | — | DP | Non-Final OA | — | Pending | Sep 10, 2024 |
| 18818523 | METHODS OF DETECTING ONCOGENIC FUSIONS AND USES THEREOF | LEITH, NANCY J | 1681 | §103§112 | Non-Final OA | 43d overdue | Pending | Aug 28, 2024 |
| 18812459 | Normalization and Calibration for Devices and Systems for Measuring Peripheral Hemodynamics | HENSON, DEVIN B | — | §101§102§103 | Non-Final OA | — | Pending | Aug 22, 2024 |
| 18837721 | SYSTEMS AND METHODS OF CORRECTING MOTION IN IMAGES FOR RADIATION PLANNING | BEKELE, MEKONEN T | — | §103 | Final Rejection | — | Pending | Aug 12, 2024 |
| 18837265 | METHODS OF ASSESSING CANCER | PRAGANI, RAJAN | 1614 | §103§112 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18780463 | Single Implantable Fiber Device for 2D Dynamic and Reconfigurable Light Emission and Collection | GREEN, TAJANAE NICOLE | — | §102§103 | Non-Final OA | — | Pending | Jul 22, 2024 |
| 18716989 | DEVICE FOR REVERSIBLY BLOCKING ACTIVITIES OF TARGET REGION AND APPLICATIONS OF SAME | CLARK, RYAN T | 3794 | §102§103 | Final Rejection | 5d | Pending | Jun 06, 2024 |
| 18732214 | ANTI-ROXP ANTIBODIES AND USES THEREOF | MORGAN, BAILEY MICHELLE | 1645 | §112 | Non-Final OA | — | Pending | Jun 03, 2024 |
| 18666803 | RHODOPSEUDOMONAS PALUSTRIS TIE-1 STRAINS AND METHODS FOR BIOPLASTIC PRODUCTION | MORGAN, BAILEY MICHELLE | 1645 | §103§112 | Non-Final OA | — | Pending | May 16, 2024 |
| 18646961 | SEPARATORS HAVING OPPOSITELY-CHARGED REGIONS AND SECONDARY BATTERIES INCLUDING THE SAME | MEKHLIN, ELI S | — | §102§103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18638327 | DEEP NEURAL NETWORKS FOR OUTCOME-ORIENTED PREDICTIONS | PARK, EDWARD | 2675 | §101§103 | Non-Final OA | 62d | Pending | Apr 17, 2024 |
| 18623995 | REGULATOR OF TUMOR CELL FUNCTIONS AND USES THEREOF | CHEONG, CHEOM-GIL | 1645 | §103§112 | Non-Final OA | — | Pending | Apr 01, 2024 |
| 18620007 | ELECTROPORATION AND ELECTROPHORESIS DEVICES, SYSTEMS, AND METHODS RELATED TO ENDOVASCULAR APPLICATIONS | FAIRCHILD, MALLIKA DIPAYAN | 3792 | §103§112 | Final Rejection | 20d | Pending | Mar 28, 2024 |
| 18693320 | SYSTEMS AND METHODS FOR FOCUSED ULTRASOUND-ENABLED LIQUID BIOPSY | HEALY, NOAH MICHAEL | 3791 | §112 | Non-Final OA | — | Pending | Mar 19, 2024 |
| 18600769 | METHODS AND SYSTEMS FOR EXTENDED CULTURE OF HUMAN BLASTOIDS TO POST-IMPLANTATION STAGES ON 3D MATRICES | PRONZATI, GINA | 1633 | §102§103§112 | Non-Final OA | — | Pending | Mar 10, 2024 |
| 18590933 | AEROSOL CONTAINMENT MASK AND METHODS OF USE THEREOF | LEE, MICHELLE J | 3786 | §102§103§112 | Final Rejection | 32d overdue | Pending | Feb 28, 2024 |
| 18586471 | METHODS AND COMPOSITIONS FOR TREATING THROMBOTIC DISEASE | BURKETT, DANIEL JOHN | 1624 | §112 | Final Rejection | — | Pending | Feb 24, 2024 |
| 18682707 | COMPOSITIONS AND METHODS FOR ENHANCING BRAIN PERFUSION | LANDSMAN, ROBERT S | — | §102§103§112 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18434796 | PRECISION RADIOPHARMACEUTICAL THERAPY OF LYMPHOMA AND OTHER DISEASES | BAEK, JONGHWAN NMN | — | §102§103 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18416578 | SYSTEMS AND METHODS FOR ATTENUATION COMPENSATION IN SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) | SORRIN, AARON JOSEPH | 2672 | §112 | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18400667 | COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY | LI, RUIXIANG | — | §102§112 | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18567428 | SYSTEMS AND METHODS FOR MONITORING PHYSIOLOGICAL STATUS OF LIVING SUBJECT AND ADMINISTERING SUBSTANCES THEREFOR | TURKOWSKI, KAYLA MARIE | 3783 | §103§112 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18516523 | PLASMA CELL-FREE RNA AND METHODS OF USE THEREOF AS NON-INVASIVE BIOMARKERS FOR ALZHEIMER'S DISEASE | HUDSON, AMY ROSE | 4100 | §101§102§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18503495 | THERAPEUTIC SPLICE-SWITCHING OLIGONUCLEOTIDES FOR CANCER | SHIN, DANA H | 1635 | §102§103§112 | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18480409 | CDK4/6 INHIBITORS AS A TREATMENT FOR CLONAL HEMATOPOIESIS | LEE, WILLIAM Y | 1623 | §102§103§112 | Non-Final OA | — | Pending | Oct 03, 2023 |
| 18553411 | COMPOSITIONS FOR BINDING SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 (S1P1), IMAGING OF S1P1, AND PROCESSES FOR PREPARATION THEREOF | JAVANMARD, SAHAR | 1622 | §103Other | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18552936 | RECHARGEABLE ANODE-FREE SODIUM METAL BATTERIES ENABLED BY NON-POROUS SODIUM METAL PLATING AND STRIPPING | SHEIKH, HAROON S | 1751 | §112 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18282933 | SURGICAL DRAIN FOR COLLECTION AND PRESERVATION OF TUMOR-ASSOCIATED BIOMARKERS IN SURGICAL DRAIN FLUID | VU, QUYNH-NHU HOANG | 3783 | §102§103 | Non-Final OA | — | Pending | Sep 19, 2023 |
| 18550797 | SPECTRAL CORRELATION ANALYSIS OF LAYERED EVOLUTIONARY SIGNALS | KALLAL, ROBERT JAMES | 2863 | §101§103§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18466073 | ELECTROLYZER | JACOBSON, SARAH JORDAN | 1785 | §102§103 | Final Rejection | — | Pending | Sep 13, 2023 |
| 18548755 | TRANSCUTANEOUS AURICULAR VAGAL NERVE STIMULATION FOR SUBARACHNOID HEMORRHAGES | STOKLOSA, JOSEPH A | 3700 | §103 | Final Rejection | — | Pending | Sep 01, 2023 |
| 18278707 | MICROBIAL PRODUCTION OF POLYMERIC AMYLOID FIBERS | JOHNSON, TIRONE DEREK | 1675 | §102§103§112 | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18231684 | MUSCLE RETENTION IN AGING AND DUCHENNE MUSCULAR DYSTROPHY (DMD) THROUGH S1P INHIBITION | YU, DAVID TUYANG | 1635 | §103§112DP | Non-Final OA | — | Pending | Aug 08, 2023 |
| 18261874 | METHODS FOR DETECTING utDNA | SALMON, KATHERINE D | 1682 | §112 | Final Rejection | 30d | Pending | Jul 18, 2023 |
| 18261483 | MHC-INDEPENDENT TCRs AND METHODS OF MAKING AND USING SAME | NICKOL, GARY B | 1643 | §112 | Final Rejection | 2d overdue | Pending | Jul 14, 2023 |
| 18260354 | ADJUSTABLE SEAL FOR FLUID MANAGEMENT SYSTEM | STUART, COLIN W | 3791 | §102§103§112 | Non-Final OA | — | Pending | Jul 05, 2023 |
| 18340417 | GENOME-EDITED INVARIANT NATURAL KILLER T (INKT) CELLS FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES | VIVLEMORE, TRACY ANN | 1638 | §103 | Non-Final OA | 70d | Pending | Jun 23, 2023 |
| 18255655 | METHODS OF TREATING AND PREVENTING KIDNEY DISEASE | SEITZ, ANTHONY JOSEPH | 1629 | §102§103 | Non-Final OA | 30d | Pending | Jun 02, 2023 |
| 18317780 | SURFACE-MODIFIED ANASTOMOSIS DEVICE | FUBARA, BLESSING M | 1613 | §102§112 | Non-Final OA | — | Pending | May 15, 2023 |
| 18316294 | METHODS OF DETECTING RESIDUAL DISEASE AND TREATMENT THEREOF | HILL, GRACELYN MARKHAM | 1699 | §101§102§103 | Non-Final OA | — | Pending | May 12, 2023 |
| 18036695 | MICROBIAL PRODUCTION OF TITIN FIBERS WITH EXCEPTIONAL MECHANICAL PERFORMANCE | TSAY, MARSHA M | 1656 | §101§102 | Non-Final OA | 21d | Pending | May 12, 2023 |
| 18311338 | SYSTEMS AND METHODS FOR EVALUATION AND PREDICTION OF RISK OF MALIGNANT EDEMA AFTER STROKE | BEGEMAN, ANDREW W | 3798 | §101§103§112 | Non-Final OA | — | Pending | May 03, 2023 |
| 18310412 | ULTRAHIGH-SPEED MULTI-PARAMETRIC PHOTOACOUSTIC MICROSCOPY BASED ON A THIN-FILM OPTICAL-ACOUSTIC COMBINER | MENDOZA, ALEXANDRIA ARELLANO | 2877 | §103§112 | Non-Final OA | 93d overdue | Pending | May 01, 2023 |
| 18140367 | HYDROGEL ASSISTED STEREOLITHOGRAPHIC ELASTOMER PROTOTYPING | MAYY, MOHAMMAD | 1718 | §103 | Final Rejection | — | Pending | Apr 27, 2023 |
| 18298355 | UNSUPERVISED DISCOVERY OF TUMOR MICROENVIRONMENTAL COMMUNITIES | KALLAL, ROBERT JAMES | — | §101§103 | Non-Final OA | — | Pending | Apr 10, 2023 |
| 18297497 | SYSTEMS AND METHODS FOR COMPUTATIONAL DESIGN OF CRISPR GUIDE RNAS FOR STRAIN-SPECIFIC CONTROL OF MICROBIOTA CONSORTIA | CANTRELL, MARANDA SHURIE | — | §101§102§103§112 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18029210 | METHODS TO DETERMINE RISK OF NEUROTOXICITY | ALABI, OYELEYE A | 1797 | §103 | Final Rejection | 30d overdue | Pending | Mar 29, 2023 |
| 18168955 | METHODS OF DETERMINING COVID-19 MORTALITY RISK | KAPUSHOC, STEPHEN THOMAS | 1683 | §101§102§103§112 | Non-Final OA | 9d | Pending | Feb 14, 2023 |
| 18164502 | CELLS AND METHODS OF USES AND MAKING THE SAME | SINGH, ANOOP KUMAR | 1632 | §103 | Non-Final OA | 70d | Pending | Feb 03, 2023 |
| 18162387 | COMPOSITIONS AND METHODS FOR SUSTAINED OXYGEN RELEASE TO ISCHEMIC TISSUES | SAEED, ALI S | 1616 | §103 | Final Rejection | — | Pending | Jan 31, 2023 |
| 18007677 | CORONAVIRUS VACCINE CONSTRUCTS AND METHODS OF MAKING AND USING SAME | EBBINGHAUS, BRIANA NOEL | 1632 | §103Other | Non-Final OA | — | Pending | Dec 01, 2022 |
| 18054503 | PARALLEL SINGLE-CELL REPORTER ASSAYS AND COMPOSITIONS | PHAM, KHAI QUYNH TIEN | 1684 | §103 | Final Rejection | 91d overdue | Pending | Nov 10, 2022 |
| 17923029 | METHODS FOR TREATING OR REDUCING THE SEVERITY OF A VIRAL INFECTION | BELYAVSKYI, MICHAIL A | 1644 | §103 | Non-Final OA | 105d overdue | Pending | Nov 03, 2022 |
| 17918933 | METHODS AND COMPOSITIONS FOR IMPROVING SC-BETA CELLS OR ENHANCING THEIR UTILITY | BERKE-SCHLESSEL, DAVID W | 1651 | §103§112DPOther | Final Rejection | 70d | Pending | Oct 14, 2022 |
| 17918792 | SARS COV-2 VACCINES AND HIGH THROUGHPUT SCREENING ASSAYS BASED ON VESICULAR STOMATITIS VIRUS VECTORS | YAO, LEI | 1642 | §112 | Final Rejection | 29d | Pending | Oct 13, 2022 |
| 18045744 | COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME | LEE, HOI YAN NMN | 1693 | §103 | Non-Final OA | 49d overdue | Pending | Oct 11, 2022 |
| 17761594 | COMPOSITIONS AND METHODS FOR MICROBIOME MODULATION | SINGH, SATYENDRA K | 1657 | §103 | Final Rejection | — | Pending | Oct 11, 2022 |
| 17916180 | IMPLANT DEVICES AND METHODS FOR TREATMENT OF CERVICAL CANCER | WORSHAM, JESSICA N | 1615 | §102§103 | Non-Final OA | 8d overdue | Pending | Sep 30, 2022 |
| 17914817 | Uses of Tau Phosphosites as Biomarkers for Alzheimer's Disease | FONTAINHAS, AURORA M | 1675 | §101§103 | Final Rejection | 42d overdue | Pending | Sep 27, 2022 |
| 17801776 | METHODS OF USE OF ANTI-TREM2 ANTIBODIES | WANG, CHANG YU | 1675 | §112Other | Non-Final OA | — | Pending | Aug 23, 2022 |
| 17800171 | SYSTEMS AND METHODS FOR PERFORMING OPTICAL IMAGING USING DUO-SPOT POINT SPREAD FUNCTIONS | NGO, BRIAN | 2851 | §103 | Final Rejection | 32d overdue | Pending | Aug 16, 2022 |
| 17798514 | CSF PHOSPHORYLATED TAU AND AMYLOID BETA PROFILES AS BIOMARKERS OF TAUOPATHIES | DUNN, MCKENZIE A | 1678 | §101§103 | Final Rejection | — | Pending | Aug 09, 2022 |
| 17809713 | SYSTEMS AND METHODS FOR TRAINING ENERGY-EFFICIENT SPIKING GROWTH TRANSFORM NEURAL NETWORKS | THAI, JASMINE THANH | 2129 | §103 | Non-Final OA | — | Pending | Jun 29, 2022 |
| 17786255 | CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELLS (CAR-DCS) AND METHODS OF MAKING AND USING SAME | ZHU, JIANJIAN | 1631 | §103Other | Final Rejection | 27d | Pending | Jun 16, 2022 |
| 17837224 | COMPOSITIONS AND METHODS FOR INCREASING CELL SURFACE OXYTOCIN RECEPTOR (OXTR) | HUTTER, GILLIAN A | 1625 | §103 | Final Rejection | 3d overdue | Pending | Jun 10, 2022 |
| 17778079 | Methods and Compositions for Generating Functionally Mature Beta Cells and Uses Thereof | SPENCER, ANDREA LYNNE MORRIS | 1631 | §102§103§112 | Final Rejection | — | Pending | May 19, 2022 |
| 17776186 | LIPOSOME COMPOSITIONS AND METHODS OF TREATMENT TARGETED TO TUMOR ENDOTHELIUM | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | §103 | Non-Final OA | 4d overdue | Pending | May 11, 2022 |
| 17735586 | SYSTEMS AND METHODS OF ADAPTIVE RADIOTHERAPY WITH CONVENTIONAL LINEAR PARTICLE ACCELERATOR (LINAC) RADIOTHERAPY DEVICES | VIRK, ADIL PARTAP S | 3798 | §103§112 | Non-Final OA | — | Pending | May 03, 2022 |
| 17731195 | Sensors for Aromatic Compounds and Methods of Making and Using Same | WARD, AARON DUREL | 1636 | §102§103§112 | Non-Final OA | — | Pending | Apr 27, 2022 |
| 17699053 | GENOME SEQUENCING AS AN ALTERNATIVE TO CYTOGENETIC ANALYSIS | SMITH, EMILIE ALINE | 1686 | §101§103 | Final Rejection | 169d overdue | Pending | Mar 18, 2022 |
| 17694679 | Automated Interpretation of Protein Capillary Electrophoresis Data | SCHULTZHAUS, JANNA NICOLE | 1685 | §101§103§112 | Final Rejection | — | Pending | Mar 15, 2022 |
| 17634843 | METHODS TO DETECT MTBR TAU ISOFORMS AND USE THEREOF | RAMADAN, OMAR | 1678 | §101§102§103§112 | Final Rejection | — | Pending | Feb 11, 2022 |
| 17628497 | PARTICLE-BASED METHOD FOR DEFINING A GUT MICROBIOTA IN HUMANS OR OTHER ANIMAL SPECIES | JONES, DAMERON LEVEST | 1618 | §103§112 | Non-Final OA | 36d overdue | Pending | Jan 19, 2022 |
| 17574524 | METHOD TO PERFORM SPECTRAL BIOPSY OF ELECTROPHYSIOLOGICAL BRAIN FUNCTION | MORONESO, JONATHAN DREW | 3791 | §101§103§112 | Final Rejection | 28d | Pending | Jan 12, 2022 |
| 17610578 | AUDITORY PROSTHETIC DEVICES USING EARLY AUDITORY POTENTIALS AS A MICROPHONE AND RELATED METHODS | GEDEON, BRIAN T | 3796 | §103 | Non-Final OA | — | Pending | Nov 11, 2021 |
| 17422051 | MULTIPLEXED ASSAY AND METHODS OF USE THEREOF | DUNN, MCKENZIE A | 1678 | §101§103 | Non-Final OA | — | Pending | Jul 09, 2021 |
| 16798204 | PHOTOACOUSTIC COMPUTED TOMOGRAPHY (PACT) SYSTEMS AND METHODS | SABOKTAKIN, MARJAN | 3797 | §103 | Non-Final OA | — | Pending | Feb 21, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial